Case Study

Developing a direct-to-employer strategy for gross-to-net optimization

Learn how Acumetis evaluated a direct-to-employer strategy, identify partnership opportunities, and develop a roadmap to support GTN improvement and future commercialization decisions.

FRM Proactivity: Reduce enrollment errors and accelerate turnaround time

Discover how proactive FRM engagement, data-driven case prioritization, and cross-functional tracking improved efficiency, reduced enrollment errors, and accelerated patient access.

How to use early modeling to assess price potential and HTA strategy

Learn how early modeling supports pricing strategy, HTA planning, cost-effectiveness assessment, and evidence generation to strengthen market access decision-making.

Strategic competitor analysis for gene therapy markets

Explore how gene therapy competitor analysis supports market entry strategy, competitive intelligence, market access planning, and long-term commercialization success.

Maximizing market potential with target patient population analysis

Explore how our team curated a target patient population analysis supporting pediatric and adult commercialization strategy, market assessment, and long-term growth planning.

Strategic launch in a rare hematologic disease

Explore how Acumetis supported launch readiness for a novel rare hematologic disease therapy through scientific positioning, stakeholder engagement, KOL insights, and cross-functional Medical Affairs strategy.

Optimizing Clinical Endpoints for Phase III Design

A Medical Affairs case study demonstrating how evidence review and stakeholder insight were used to refine clinically meaningful endpoints and support Phase III trial design and regulatory dialogue.

How to achieve HTA submission success for rare disease therapies

A case study illustrating how an evidence‑led, strategically aligned HTA approach can address uncertainty and strengthen submissions for rare disease therapies.

Communication strategy for novel MOA in neurological disorder

To support a novel mechanism of action in a complex neurological indication, Acumetis delivered a focused life sciences commercialization consulting strategy that aligned science, stakeholders, and evidence generation. By integrating...